- Home
- BCG vs BRNS Comparison
BCG vs BRNS Comparison
Compare BCG & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCG
- BRNS
- Stock Information
- Founded
- BCG 2016
- BRNS 2016
- Country
- BCG United States
- BRNS United Kingdom
- Employees
- BCG N/A
- BRNS N/A
- Industry
- BCG
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- BCG
- BRNS Health Care
- Exchange
- BCG Nasdaq
- BRNS Nasdaq
- Market Cap
- BCG 54.3M
- BRNS 52.0M
- IPO Year
- BCG N/A
- BRNS 2021
- Fundamental
- Price
- BCG $2.55
- BRNS $1.18
- Analyst Decision
- BCG
- BRNS Strong Buy
- Analyst Count
- BCG 0
- BRNS 2
- Target Price
- BCG N/A
- BRNS $4.00
- AVG Volume (30 Days)
- BCG 11.3K
- BRNS 38.8K
- Earning Date
- BCG 08-15-2024
- BRNS 11-07-2024
- Dividend Yield
- BCG N/A
- BRNS N/A
- EPS Growth
- BCG N/A
- BRNS N/A
- EPS
- BCG N/A
- BRNS N/A
- Revenue
- BCG $161,897,000.00
- BRNS N/A
- Revenue This Year
- BCG N/A
- BRNS $27.18
- Revenue Next Year
- BCG N/A
- BRNS N/A
- P/E Ratio
- BCG N/A
- BRNS N/A
- Revenue Growth
- BCG N/A
- BRNS N/A
- 52 Week Low
- BCG $2.45
- BRNS $1.11
- 52 Week High
- BCG $16.61
- BRNS $5.10
- Technical
- Relative Strength Index (RSI)
- BCG N/A
- BRNS 42.20
- Support Level
- BCG N/A
- BRNS $1.15
- Resistance Level
- BCG N/A
- BRNS $1.35
- Average True Range (ATR)
- BCG 0.00
- BRNS 0.07
- MACD
- BCG 0.00
- BRNS -0.00
- Stochastic Oscillator
- BCG 0.00
- BRNS 19.05
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.